* Predictive Oncology Inc POAI.OQ POAI.O is expected
to show a
rise in quarterly revenue when it reports results on May 10
(estimated).
* The Eagan Minnesota-based company is expected to report
a
256.7% increase in revenue to $1 million from $280.32 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Predictive Oncology
Inc
is for a loss of 4 cents per share. For the same quarter last
year, the company reported a loss of 11 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Predictive
Oncology Inc is $5, above its last closing price of $0.73.
This summary was machine generated May 6 at 20:45 GMT. All
figures in US dollars unless otherwise stated